CD44 and melanoma: In addition, a screen of 51 monoclonal antibodies against cell surface molecules identified two mAbs that blocked coalescence in the 3D Matrigel model, one against beta-1-integrin (CD29) [47], and one against CD44, the hyaluronate adhesion receptor implicated in melanoma metastasis [48–54].